News People & Careers
Evonik: CEO contract extended and new CFO appointed
The supervisory board of Essen-based speciality chemicals company Evonik has made significant personnel decisions: Christian Kullmann will continue as CEO until 2030, and Michael Rauch will take over as CFO starting 1 May.
Both resolutions were passed unanimously, strengthening the company’s stability and ability to navigate challenging economic conditions.
Christian Kullmann, who has been with the company since 2003 and has led the board since 2017, enjoys widespread trust and support. Michael Rauch brings extensive expertise from the chemical and financial sectors, having held senior positions at Henkel, Douglas, and Selecta AGHis financial acumen and experience in managing business transformations are expected to contribute significantly to Evonik’s resilience in the face of market fluctuations.
Rauch succeeds Kullmann, who has been managing the finance portfolio on an interim basis since September. Dr Claus Rettig, who provided operational support during this period, will now fully focus on his role as head of the Asia-Pacific region. Rauch will officially introduce himself to Evonik’s shareholders during the Annual General Meeting on 3 June.
